Aug 4 Cardiology News
Behavior counseling in type 2 diabetes, FDA regulation of tobacco, cuff BP readings, smoking cessation, and CV genetics are discussed this week. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - August 4, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
JAMA Internal Medicine : Glucose Self-monitoring in Non –Insulin-Treated Patients With Type 2 Diabetes
Interview with Laura Young, MD PhD, and Katrina E. Donahue, MD, MPH, authors of Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 10, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
FDA Drug Safety Podcast: FDA confirms increased risk of leg and foot amputations with the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR)
On May 16, 2017, based on new data from two large clinical trials, the FDA concluded that the type 2 diabetes medicine canagliflozin (brand names Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - May 25, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Oral Agents and Insulin: What, and for How Long?
Drs Shubrook and Healy discuss optimal patient approaches to balancing insulin, SGLT2 inhibitors, and oral agents in the management of uncontrolled type 2 diabetes. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - April 24, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts
Oral Agents and Insulin: What, and for How Long?
Drs Shubrook and Healy discuss optimal patient approaches to balancing insulin, SGLT2 inhibitors, and oral agents in the management of uncontrolled type 2 diabetes. (Source: Medscape Nurses Podcast)
Source: Medscape Nurses Podcast - April 24, 2017 Category: Nursing Authors: Medscape Source Type: podcasts
PodMed – Week of April 17, 2017http://podcasts.hopkinsmedicine.org/2017/04/14/podmed-week-of-april-17-2017/
This week’s topics include deaths relative to diabetes, increases in both type 1 and type 2 diabetes among US youth, the benefits of spinal manipulation for low back pain, and draft recommendations regarding prostate cancer screening. Program notes: 0:40 Prostate cancer screening 1:38 Clinicians should inform on risks and benefits 2:40 Outcomes for 1000 men […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - April 14, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Johns Hopkins Medicine Tags: All Podcasts Breast Health Cancer Diabetes Pain And Pain Relief PodMed Prostate Health Source Type: podcasts
Premixed Insulin: Best Practice Strategies
What are the pros and cons of using premixed insulin, both human and analog, in patients with type 2 diabetes? (Source: Medscape Nurses Podcast)
Source: Medscape Nurses Podcast - March 27, 2017 Category: Nursing Authors: Medscape Source Type: podcasts
Premixed Insulin: Best Practice Strategies
What are the pros and cons of using premixed insulin, both human and analog, in patients with type 2 diabetes? (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 27, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts
New Diabetes Drugs in Development
Dr John Buse highlights some of the new drugs and devices being developed for type 2 and type 1 diabetes. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 10, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts
FDA Drug Safety Podcast: Updated FDA review concludes that use of pioglitazone may be linked to an increased risk of bladder cancer
On December 12, 2016, FDA announced as a result of an updated review, that it has concluded that use of the type 2 diabetes medicine pioglitazone (brand names Actos, Actoplus Met, Actoplus Met XR, Duetact, Oseni) may be linked to an increased risk of bladder cancer. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 9, 2017 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Trends in secondary cancers after childhood cancer treatment, comparison of type 1 vs type 2 diabetes complications in childhood and adolescence, overuse of services as an adverse event, and more
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 28, 2017 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 28, 2017 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
Diabetes Core Update - March 2017
Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 15 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatmen...
Source: Diabetes Core Update - February 24, 2017 Category: Endocrinology Authors: American Diabetes Association Source Type: podcasts
